CRONOS GROUP INC. Other than Temporary Impairment Losses, Investments
CRONOS GROUP INC. (CRON) reported Other than Temporary Impairment Losses, Investments of $61.39 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfInvestments · last filed 2023-02-28
- CRONOS GROUP INC. other than temporary impairment losses, investments for the quarter ending 2022-12-31 was $21.18M.
- CRONOS GROUP INC. other than temporary impairment losses, investments for the quarter ending 2022-09-30 was $28.97M.
- CRONOS GROUP INC. other than temporary impairment losses, investments for the quarter ending 2022-06-30 was $0.00.
- CRONOS GROUP INC. other than temporary impairment losses, investments for the quarter ending 2022-03-31 was $11.24M.
- CRONOS GROUP INC. other than temporary impairment losses, investments for fiscal 2022 was $61.39M.
- CRONOS GROUP INC. other than temporary impairment losses, investments for fiscal 2021 was $0.00.
- CRONOS GROUP INC. other than temporary impairment losses, investments for fiscal 2020 was $0.00.
| Period end | Other than Temporary Impairment Losses, Investments 3 month | Other than Temporary Impairment Losses, Investments 6 month | Other than Temporary Impairment Losses, Investments 9 month | Other than Temporary Impairment Losses, Investments 12 month |
|---|---|---|---|---|
| 2022-12-31 | $21.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $50.15M derived: sum of 2 quarters · filed 2023-02-28 | $50.15M derived: sum of 3 quarters · filed 2023-02-28 | $61.39M 10-K · filed 2023-02-28 |
| 2022-09-30 | $28.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $28.97M derived: sum of 2 quarters · filed 2022-11-07 | $40.21M 10-Q · filed 2022-11-07 | $40.21M derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 | $11.24M 10-Q · filed 2022-08-09 | $11.24M derived: sum of 3 quarters · filed 2023-02-28 | $11.24M derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-03-31 | $11.24M 10-Q · filed 2022-05-10 | $11.24M derived: sum of 2 quarters · filed 2023-02-28 | $11.24M derived: sum of 3 quarters · filed 2023-02-28 | $11.24M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $0.00 derived: sum of 2 quarters · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |